Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Viekira Pak-RBV

Viekira Pak-RBV is a medicine containing the active ingredient(s) ribavirin, paritaprevir + ritonavir + ombitasvir, dasabuvir. On this page you will find out more about Viekira Pak-RBV, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: ribavirin

Active ingredient in this medicine: paritaprevir + ritonavir + ombitasvir

Active ingredient in this medicine: dasabuvir

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Viekira Pak-RBV (4 x 28 x Viekira Pak tablets, 168 x Ribavirin (Abbvie) 200 mg tablets), 1 pack

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

VIEKIRA PAK-RBV is indicated for the treatment of genotype 1 chronic hepatitis C infection, including patients with compensated cirrhosis. Duration of therapy and addition of ribavirin are dependent on patient population (see DOSAGE AND ADMINISTRATION, PRECAUTIONS, CLINICAL TRIALS).

Table of characteristics
Table of characteristics
Active ingredient
Medicine schedule
280 Tablets (56 x paritaprevirr/ritonavir/ombitasvir tablets + 56 x dasabuvir tablets) + 168 x ribavirin tablets: Prescription Only Medicine, or Prescription Animal Remedy
Part 1
Part 1
Visual appearance light-blue, oblong-shaped and debossed with "200" on one side and "3RP" on the other side
Dosage Form Tablet, film coated
Route of administration Oral
Part 2
Part 2
Visual appearance beige-colored, oval-shaped, debossed with "AV2" on one side
Dosage Form Tablet, film coated
Route of administration Oral
Part 3
Part 3
Visual appearance pink-colored, oblong biconvex shaped, debossed with "AV1" on one side
Dosage Form Tablet, film coated
Route of administration Oral

There is one type of pack available.

Pack type 1
Pack type 1
Type Carton
Storage temperature Store below 25 degrees Celsius
Storage conditions Store in Original Container,Store in a Dry Place
Life time 3 Years
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 2 results

Viekira Pak-RBV (200) Combination Therapy Pack Tablets - myDr.com.au

Viekira Pak-RBV (200) Combination Therapy Pack Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Managing hepatitis C in general practice | Issue 2 | Volume 40 | Australian Prescriber | Australian Prescriber

What are the essential steps in treating hepatitis C in primary care and when should you refer patients with hepatitis C to a specialist or liver clinic?

Read more on Australian Prescriber website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback